Document Detail

Antibiotics and antifungals in neonatal intensive care units: a review.
MedLine Citation:
PMID:  17309846     Owner:  NLM     Status:  MEDLINE    
The incidence of infections is higher in the neonatal period than at any time of life. The basic treatment of infants with infection has not changed substantially over the last years. Antibiotics (with or without supportive care) are one of the most valuable resources in managing sick newborn babies. Early-onset (ascending or transplacental) or late-onset (hospital acquired) infections present different chronology, epidemiology, physiology and outcome. Some classes of antibiotics are frequently used in the neonatal period: penicillins, cephalosporins, aminoglycosides, glycopeptides, monobactams, carbapenems. Other classes of antibiotics (chloramphenicol, cotrimoxazole, macrolides, clindamycin, rifampicin and metronidazole) are rarely used. Due to emergence of resistant bacterial strains in Neonatal Intensive Care Units (NICU), other classes of antibiotics such as quinolones and linezolid will probably increase their therapeutic role in the future. Although new formulations have been developed for treatment of fungal infections in infants, amphotericin B remains first-line treatment for systemic Candida infection. Prophylactic antibiotic therapy is almost always undesirable. Challenges from pathogens and antibiotic resistance in the NICU may warrant modification of traditional antibiotic regimens. Knowledge of local flora and practical application of different antibiotic characteristics are key to an effective and safe utilization of antibiotics and antifungals in critical newborns admitted to the NICU, and especially in very low birth weight infants.
V Fanos; L Cuzzolin; A Atzei; M Testa
Related Documents :
12540416 - Ingested probiotics reduce nasal colonization with pathogenic bacteria (staphylococcus ...
8201486 - Frequency and significance of isolation of ureaplasma urealyticum and mycoplasma homini...
11788926 - Myeloid hematopoietic growth factors and their role in prevention and/or treatment of n...
19926166 - Routine antibiotic use in preterm neonates: a randomised controlled trial.
19368696 - Five-month-old infants have different expectations for solids and liquids.
21542536 - Immune thrombocytopenic purpura in pregnancy: a reappraisal of obstetric management and...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of chemotherapy (Florence, Italy)     Volume:  19     ISSN:  1120-009X     ISO Abbreviation:  J Chemother     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-20     Completed Date:  2007-04-10     Revised Date:  2009-08-04    
Medline Journal Info:
Nlm Unique ID:  8907348     Medline TA:  J Chemother     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  5-20     Citation Subset:  IM    
Neonatal Intensive Care Unit - University of Cagliari, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis
Antifungal Agents / therapeutic use*
Drug Resistance, Microbial
Infant, Newborn
Intensive Care Units, Neonatal*
Sepsis / drug therapy*
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Antifungal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Homebuilt single-molecule scanning confocal fluorescence microscope studies of single DNA/protein in...
Next Document:  COX-2 inhibition: a possible role in the management of prostate cancer?